Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.

PHASE4UnknownINTERVENTIONAL
Enrollment

2,948

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2013

Conditions
AtherosclerosisCardiovascular Diseases
Interventions
DRUG

Simvastatin or Atorvastatin

Simvastatin 10-40 mg or Atorvastatin 20-40 mg will be prescribed according to LDL cholesterol reduction target.

DRUG

Enalapril

Enalapril 10 mg/day will be prescribed as the initial treatment. Doses and adding drugs will be titrated accordingly

DRUG

Aspirin or clopidogrel

Aspirin 100 mg or clopidogrel 75 mg/ per day

DRUG

Rimonabant

"In both arms, we will follow the standard clinical care in terms of treatments, as far as obesity and diabetes mellitus is concerned.~Drugs will be prescribed as the standard clinical care"

Trial Locations (1)

25260

RECRUITING

Hospital Arnau de Vilanova, Lleida

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Hospital Arnau de Vilanova

OTHER

NCT00734123 - Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases. | Biotech Hunter | Biotech Hunter